These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 367679)

  • 21. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer.
    Saunders MI; Rojas AM; Parmar MK; Dische S;
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):3-8. PubMed ID: 20394851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients.
    Geara FB; Peters LJ; Ang KK; Wike JL; Brock WA
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1173-9. PubMed ID: 8262844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer.
    Fowler JF
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1451-6. PubMed ID: 1938553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal tissue reactions in the British Institute of Radiology Study of 3 fractions per week versus 5 fractions per week in the treatment of carcinoma of the laryngo-pharynx by radiotherapy.
    Rezvani M; Alcock CJ; Fowler JF; Haybittle JL; Hopewell JW; Wiernik G
    Br J Radiol; 1991 Dec; 64(768):1122-33. PubMed ID: 1773272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.
    Sealy R; Cridland S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of conventional versus high fractional dose radiation therapy in the treatment of advanced head and neck cancer.
    Weissberg JB; Son YH; Percarpio B; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):179-85. PubMed ID: 6806218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twice-a-day irradiation technique for squamous cell carcinomas of the head and neck.
    Million RR; Parsons JT; Cassisi NJ
    Cancer; 1985 May; 55(9 Suppl):2096-9. PubMed ID: 3919924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
    Bartelink H; Van den Bogaert W; Horiot JC; Jager J; van Glabbeke M
    Eur J Cancer; 2002 Mar; 38(5):667-73. PubMed ID: 11916549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What can we learn from the hyperbaric oxygen trials in head and neck cancer?
    Hartmann KA; Carl UM; Bahnsen J
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():26-7. PubMed ID: 8946043
    [No Abstract]   [Full Text] [Related]  

  • 32. Twice-a-day radiation therapy for cancer of the head and neck.
    Wang CC; Blitzer PH; Suit HD
    Cancer; 1985 May; 55(9 Suppl):2100-4. PubMed ID: 3919925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective randomized trial to compare accelerated (six fractions a week) radiotherapy against concurrent chemoradiotherapy (using conventional fractionation) in locally advanced head and neck cancers.
    Gupta M; Mahajan R; Kaushal V; Seem RK; Gupta M; Bhattacharyya T
    J Cancer Res Ther; 2015; 11(4):723-9. PubMed ID: 26881508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
    Lee DJ; Pajak TF; Stetz J; Order SE; Weissberg JB; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation therapy of head and neck tumors: a randomized study of treatment in air vs. treatment in hyperbaric oxygen.
    Sause WT; Plenk HP
    Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1833-6. PubMed ID: 528245
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperbaric oxygen: the Medical Research Council trials and their clinical significance.
    Dische S
    Br J Radiol; 1978 Nov; 51(611):888-94. PubMed ID: 361145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.
    Marcu L; Bezak E
    Phys Med; 2010 Oct; 26(4):177-83. PubMed ID: 20034829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
    Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.